Dr. Kenneth Chapman, M.D., M.Sc., F.R.C.P.C, F.A.C.P.
President, Inspiration Research Limited
Director, Asthma & Airway Centre, University Health Network
GSK-CIHR Researhch Chair in Respiratory Health Care Delivery
Dr. Kenneth Chapman is the founder and current president of Inspiration Research Limited. He is also the director of the Asthma and Airway Centre at the University Health Network. A graduate of the University of Toronto and a former member of the faculty at Case Western Reserve University, he is now a Professor of Medicine at the University of Toronto. He chaired Canada’s first Consensus Conference to establish Canadian guidelines for the management of COPD. Dr. Chapman has recently been named to the CIHR-GSK Research Chair in Respiratory Health Care Delivery.
Dr. Chapman is an internationally respected researcher in the field of asthma, chronic obstructive pulmonary disease (COPD) and airway diseases. His publications have appeared in the New England Journal of Medicine and the Lancet. The titles of more than 400 publications ranges "Emergency medical services for outdoor rock music festivals" to "The effect of posture on thoracoabdominal movements during progressive hyperoxic hypercapnia in conscious man". Dr. Chapman has been cited more than 6000 times.
Research Highlights: Asthma management strategies
It is now a standard of care that patients with unstable asthma are given a short course of oral steroids in hospital emergency rooms, walk-in clinics and offices to allow their safe discharge home. This strategy was first examined rigorously by Dr. Chapman and his colleagues who published their pivotal study in the New England Journal of Medicine *. This was followed by other studies examining the optimal strategies for managing asthma.
Optimizing asthma treatment outcomes lead inevitably to studies of patient education, compliance, and control assessment *. Doctor Chapman's work in patient education included establishing the Canadian Network for Respiratory Care, an organization that manages respiratory educator certification programs for Canada. He remains active executive member.
Chronic Obstructive Pulmonary Disease (COPD)
Dr. Chapman wrote Canada’s first guidelines for the management of COPD* and maintains a broad program of research in this area, addressing issues of diagnostic delay, epidemiology and non-invasive monitoring. He is a member of the CanCOLD consortium, a trans-Canadian program of study examining the natural history in a large population-based cohort of patients with COPD. He has addressed issues of gender bias in his work.
Alpha Antitrypsin Deficiency
Dr. Chapman follows a large number of patients with alpha1 antitrypsin deficiency* and is considered one of the world’s experts in this comparatively rare lung disease. His work reflects both the Canadian perspective (from the Canadian registry) and his collaboration with international colleagues.